Case Report
Published on 13 Oct 2025
Durable clinical benefit from gefitinib plus bevacizumab in a non-small cell lung cancer patient with an acquired C797S mutation following osimertinib treatment: a case report and literature review
in Thoracic Oncology
- 402 views